INVA
Innoviva, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.20
−0.52%Leverage
- Debt / equity
- 0.22x
- Net debt / equity
- -0.24x
- Debt / assets
- 0.16x
- Debt / EBITDA
- 0.35x
- Net debt / EBITDA
- -0.39x
Liquidity & coverage
- Current ratio
- 16.01x
- Quick ratio
- 15.18x
- Cash ratio
- 12.30x
- Interest coverage
- 8.92x
- EBITDA / interest
- 42.26x
- Working capital
- $706.3M
Cash & dividend
- FCF / debt
- 0.70x
- Cash flow / debt
- 0.71x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- +50.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026